AlphaCrest Capital Management’s Evolent Health EVH Stock Holding History

AlphaCrest Capital Management’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-18,827	Closed	-$608K	–	1284
2022 Q1	$608K	Sell	18,827 -4,748	-20%	-$124K	0.03%	802
2021 Q4	$652K	Buy	23,575 +13,275	+129%	+$381K	0.02%	991
2021 Q3	$319K	Buy	10,300 +200	+2%	+$4.8K	0.02%	1081
2021 Q2	$213K	Buy	+10,100	New	+$202K	0.01%	1184
2019 Q3	–	Sell	-16,000	Closed	-$127K	–	1269
2019 Q2	$127K	Sell	16,000 -3,800	-19%	-$45K	0.01%	989
2019 Q1	$249K	Buy	+19,800	New	+$313K	0.04%	716

Other funds holding EVH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

AlphaCrest Capital Management's EVH Position: Q2 2022 in Review

AlphaCrest Capital Management sold out of Evolent Health (EVH) in Q2 2022, closing a stake of 18,827 shares — an estimated $608K sold.

AlphaCrest Capital Management first reported a position in EVH in Q1 2019 and held it in 6 quarters. The position peaked at $652K in Q4 2021. 215 funds tracked by Wall St. Rank hold EVH as of Q2 2022.

AlphaCrest Capital Management reported no remaining Evolent Health position as of Q2 2022 after selling out during the quarter.
AlphaCrest Capital Management sold 18,827 Evolent Health shares in Q2 2022, an estimated $608K.
AlphaCrest Capital Management first reported a position in Evolent Health in Q1 2019 and held it in 6 quarters.
AlphaCrest Capital Management's Evolent Health position peaked at $652K in Q4 2021.
215 funds tracked by Wall St. Rank held Evolent Health as of Q2 2022.

Based on AlphaCrest Capital Management's 13F filing for Q2 2022, filed 11 Aug 2022.